James Turkson

Cancer Drug Discovery and Anticancer Drug Development

J. Turkson, James Turkson, 2017 .

Antagonism of the Stat3–Stat3 Protein Dimer with Salicylic Acid Based Small Molecules

Steven Fletcher, Patrick T. Gunning, P. Yue, 2011, ChemMedChem.

The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?

Jeanne Kowalski, Linzhao Cheng, Takita Felder Sumter, 2008, Cancer research.

STAT proteins as novel targets for cancer drug discovery

J. Turkson, James Turkson, 2004, Expert opinion on therapeutic targets.

Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer

Eric B Haura, J. Turkson, R. Jove, 2005, Nature Clinical Practice Oncology.

STATs in oncogenesis

Roy Garcia, J. Turkson, R. Jove, 2000, Oncogene.

Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells

J. Turkson, R. Jove, B. Elliott, 2004, Oncogene.

Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production.

Soumen Das, Jihe Zhao, Sudipta Seal, 2013, Nanomedicine : nanotechnology, biology, and medicine.